March 15, 2016 — The ongoing debate about ...
Contrast Media
Contrast media, also called contrast agents, are used to enhance the blood and perfusion in tissues. This includes iodine based contrast for on computed tomography (CT), gadolinium based agents for MRI and lipid bubble contrast agents used in ultrasound.
News | Lung Cancer | March 11, 2016
March 11, 2016 — New scanning technology which will give a much clearer picture of...
News | Prostate Cancer | February 18, 2016
February 18, 2016 — Manhattan Scientifics Inc. announced its wholly-owned subsidiary Senior Scientific LLC, which is...
Technology | Contrast Media Injectors | February 16, 2016
February 16, 2016 — Guerbet announced that it has received 510K clearance from the U.S. Food and Drug Administration...
An ultrasound-stimulated microbubble burrows through a fibrin clot (green) allowing penetration of the surrounding fluid into the clot (yellow). Image courtesy of Christopher Acconci and David Goertz, University of Toronto.
News | Ultrasound Imaging | February 11, 2016
February 11, 2016 — Researchers funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB)...
News | Contrast Media | February 04, 2016
February 4, 2016 — Akrotome Imaging Inc. received a major award from the National Institutes of Health (NIH) in...
Molecular imaging of the GRPR biomarker on mice xenografted with PC3 and H441 cells by T1-weighted spin echo MR imaging and NIR imaging.
News | Magnetic Resonance Imaging (MRI) | December 29, 2015
December 29, 2015 — A method to better trace changes in cancers and treatment of the prostate and lung without the...
News | Contrast Media | November 29, 2015
November 29, 2015 — Guerbet announced that it has completed its acquisition of the "contrast media and delivery...
Image courtesy of Access Scientific LLC
Technology | Contrast Media | November 02, 2015
November 2, 2015 — Access Scientific LLC announced validation of the Powerwand midline IV catheter for power-...
News | Contrast Media | October 21, 2015
October 21, 2015 — Bracco Diagnostics Inc. announced that Lumason was approved by the Centers for Medicare and...
Image courtesy of Galt Medical
Technology | Contrast Media Injectors | October 01, 2015
October 1, 2015 — Galt Medical has partnered with Health Line International Corp. and launched the Nexus CT Midline...
News | Oncology Diagnostics | September 18, 2015
September 18, 2015 — Edinburgh Molecular Imaging Ltd. (EM Imaging) has signed an exclusive global license for a...
News | Ultrasound Imaging | September 14, 2015
September 14, 2015 — University of Arkansas for Medical Sciences (UAMS) researcher Vladimir Zharov, Ph.D., D.Sc.,...
News | Contrast Media | September 11, 2015
September 11, 2015 — Tiny gas microbubbles can enhance the delivery and absorption of cancer drugs in patients with...
Metastasis occurs when cells are shed from primary breast cancer tumor and establish a new tumor at a distant site. For early detection of the metastasis with MRI, the Lu Lab developed a probe that binds to fibrin-fibronectin protein complexes in high-risk tumors. Fibronectin is expressed in high-risk (aggressive) cancer and not in normal tissue, so MRI imaging is able to distinguish metastases from normal tissue. Image courtesy of the National Institutes of Health.
News | MRI Breast | August 12, 2015
August 12, 2015 — Researchers have shown that...
Intraoperative image of thyroid (red) and parathyroids (green) in rats four hours after intravenous injection of targeted contrast agents. Image captured using the FLARE system. Image courtesy of Macmillan Publishers Ltd.
News | Contrast Media | July 29, 2015
July 29, 2015 — Researchers funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) have...
Feature | Contrast Media | July 28, 2015
July 28, 2015 — Guerbet announced that it has entered into a definitive agreement under which it will acquire...
Feature | Contrast Media | June 26, 2015
June 26, 2015 - New results in animals highlight a major safety concern regarding a class of...
News | June 16, 2015
June 16, 2015 - The prostate-specific membrane antigen (PSMA) biomarker is the bullseye for three new...
